SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-017529
Filing Date
2024-06-18
Accepted
2024-06-18 21:05:14
Documents
2
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 form3-06192024_010610.html 3  
1 form3-06192024_010610.xml 3 1679
2 ex24-06192024_010610.htm EX-24 5129
  Complete submission text file 0001415889-24-017529.txt   8261
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOME, INC. 18702 NORTH CREEK PARKWAY, SUITE 100 BOTHELL WA 98011
Business Address
Tsai Philip (Reporting) CIK: 0002026600 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39580 | Film No.: 241053784